Serum γ-glutamyl transferase (GGT) activity is a risk predictor for the development of coronary artery disease and is related to cardiovascular morbidity and mortality. We evaluated the clinical utility of GGT activity in predicting high troponin levels in patients with acute coronary syndrome (ACS) admitted to the emergency department with chest pain. A total of 200 troponin-positive and 203 troponin-negative patients were classified into groups 1 and 2, respectively. γ-Glutamyl transferase activity was significantly higher in group 1 (44 ± 34 U/L) compared with group 2 (31 ± 26 U/L, P = .001). A GGT activity cutoff >25.5 showed 62% sensitivity and 61% specificity in predicting troponin positivity. Logistic regression analysis demonstrated a significant predictive value of GGT for troponin positivity. Spearman rank correlation analysis showed a moderately strong relationship between GGT activity and troponin positivity. Considering the predictive value of high GGT activity for troponin positivity, GGT activity may complement other diagnostic biomarkers for predicting troponin positivity in patients having ACS admitted with chest pain.
HanssonGK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685–1695.
2.
GoldbergRJGlatfelterKBurbank-SchmidtELessardDGoreJM. Trends in community mortality due to coronary heart disease. Am Heart J. 2006;151(2):501–507.
3.
LibbyPTherouxP. Pathophysiology of coronary artery disease. Circulation. 2005;111(25):3481–3488.
4.
EmdinMPassinoCPompellaAPaolicchiA. Serum gamma-glutamyl transpeptidase: a prognostic marker in cardiovascular diseases. Biofactors. 2003;17(1-4):199–205.
5.
RuttmannEBrantLJConcinHDiemGRappKUlmerH;Vorarlberg Health Monitoring and Promotion Program Study Group. Gamma-glutamyl transferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation. 2005;112(14):2130–2137.
6.
WannametheeGEbrahimSShaperAG. Gamma-glutamyl transferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol. 1995;142(7):699–708.
PaolicchiAMinottiGTonarelliP. Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation: a potential mechanism in atherosclerosis. J Invest Med. 1999;47(3):151–160.
9.
BerlinerJAHeineckeJW. The role of oxidized lipoproteins in atherogenesis. Free Rad Biol Med. 1996;20(5):707–727.
10.
PompellaAEmdinMPassinoCPaolicchiA. The significance of serum-glutamyl transferase in cardiovascular diseases. Clin Chem Lab Med. 2004;42(10):1085–1091.
11.
BetroMGOonRCEdwardsJB. Gamma-glutamyl transpeptidase and other liver function tests in myocardial infarction and heart failure. Am J Clin Pathol. 1973;60(5):679–683.
12.
HoodBKjellstromTRuterGKristensonH. Serum cholesterol, serum triglyceride, alcohol, myocardial infarction and death: necessary to pay attention to serum GT in assessment of risks of myocardial. Lakartidningen. 1990;87(41):3295–3298.
EmdinMPassinoCMichelassiC. Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J. 2001;22(19):1802–1807.
15.
AndersonJLAdamsCDAntmanEM. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2007;50(7):e1–e157.
16.
PaolicchiAEmdinMPassinoC. Beta-lipoprotein and LDL associated serum γ-glutamyl transferase in patients with coronary atherosclerosis. Atherosclerosis. 2006;186(1):80–85.
17.
YamadaJTomiyamaHYambeM. Elevated serum levels of alanine amino transferase and gamma glutamyl transferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis. 2006;189(1):198–205.
18.
LeeDSEvansJCRobinsSJ. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2007;27(1):127–133.
19.
EmdinMPompellaAPaolicchiA. Gamma-glutamyl transferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation. 2005;112(14):2078–2080.
20.
EmirogluMYEsenOBBulutMKarapinarHKayaZAkcakoyunM. GGT levels in type II diabetic patients with acute coronary syndrome (does diabetes have any effect on GGT levels in acute coronary syndrome?). Acta Diabetol. 2013;50(1):21–25.
21.
DoganAIcliAAksoyF. Gamma-glutamyl transferase in acute coronary syndrome patients without ST elevation and its association with stenotic lesion and cardiac events. Coron Artery Dis. 2012;23(1):39–44.
22.
UlusTYildirirASadeLE. Serum gamma-glutamyl transferase activity: new high-risk criteria in acute coronary syndrome patients?Coron Artery Dis. 2008;19(7):489–495.
23.
EmirogluMYEsenOBBulutM. Gamma glutamyl transferase levels and its association with high sensitive C-reactive protein in patients with acute coronary syndromes. N Am J Med Sci. 2010;2(7):306–310.
24.
EmdinMPassinoCMichelassiCDonatoLPompellaAPaolicchiA. Additive prognostic value of gamma-glutamyl transferase in coronary artery disease. Int J Cardiol. 2009;136(1):80–85.
25.
ZhangGYChenMYuZMWangXDWangZQ. Relation between neutrophil-to-lymphocyte ratio and severity of coronary artery stenosis. Genet Mol Res. 2014;13(4):9382–9389.
26.
TamhaneUUAnejaSMontgomeryDRogersEKEagleKAGurmHS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102(6):653–657.
27.
GaziEBayramBGaziS. Prognostic value of the neutrophil-lymphocyte ratio in patients with st-elevated acute myocardial infarction. Clin Appl Thromb Hemost. 2015;21(2):155–159.
28.
MuhmmedSulimanMABahnacyJumaAAAli AlmadhaniAAPathareAVAlkindiSSUwe WernerF. Predictive value of neutrophil to lymphocyte ratio in outcomes of patients with acute coronary syndrome. Arch Med Res. 2010;41(8):618–622.
29.
KorkmazAYildizAGunesH. Utility of neutrophil-lymphocyte ratio in predicting troponin elevation in the emergency department setting. Clin Appl Thromb Hemost. 2015;21(7):667–671.
30.
TimmerJRvan der HorstICOttervangerJP. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J. 2004;148(3):399–404.
31.
MonteiroSMonteiroPGoncalvesFFreitasMProvidenciaLA. Hyperglycaemia at admission in acute coronary syndrome patients: prognostic value in diabetics and non-diabetics. Eur J Cardiovasc Prev Rehabil. 2010;17(2):155–159.
